Amarin Corp Plc (AMRN)

[Biobillionair]

Agree, you have eloquently summed up the scheme minus the government sponsored “takings” of patents rights. In our circumstance Hikma ignored R-I OB patents because if they filed a paragraph 4 it would have triggered a statutory 30 month stay....instead Hikma is now playing chicken with a freight train with no breaks.

Hikma needs to explain in their Delaware response why they chose to ignore the generic drug scheme and instead just rob Amarin and stakeholders blind. Hikma either did not check the Orange Book or intentionally ignored the content. The other problem Hikma has; Hikma had a chance to complain about any patent and or patent use code Amarin placed in the OB...obviously they did not.

Why does Hikma need two months to respond to Delaware complaint? There is no defense against not abiding with checking OB and filing paragraph 4s.

BB